M&T Bank Corp Iovance Biotherapeutics, Inc. Transaction History

M&T Bank Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$28.67 - $52.59 $395,244 - $725,005	-13,786 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$28.04 - $50.26 $23,553 - $42,218	840 Added 6.49%	13,786 $640,000
Q3 2020 Nov 06, 2020	BUY	$27.75 - $36.3 $74,841 - $97,901	2,697 Added 26.31%	12,946 $427,000
Q2 2020 Jul 29, 2020	BUY	$27.21 - $41.0 $11,428 - $17,220	420 Added 4.27%	10,249 $281,000
Q1 2020 May 14, 2020	SELL	$19.54 - $38.85 $22,881 - $45,493	-1,171 Reduced 10.65%	9,829 $294,000
Q2 2019 Aug 12, 2019	BUY	$9.78 - $24.52 $107,580 - $269,720	11,000 New	11,000 $270,000

319

238M

1.27M

1.68M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.74B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.